ALPINE IMMUNE SCIENCES, INC. Debt Conversion, Converted Instrument, Amount
ALPINE IMMUNE SCIENCES, INC. reported Debt Conversion, Converted Instrument, Amount of $24.66 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-02-13
- ALPINE IMMUNE SCIENCES, INC. debt conversion, converted instrument, amount for the quarter ending 2014-12-31 was -$45.00K.
- ALPINE IMMUNE SCIENCES, INC. debt conversion, converted instrument, amount for the quarter ending 2014-09-30 was $12.34M.
- ALPINE IMMUNE SCIENCES, INC. debt conversion, converted instrument, amount for fiscal 2014 was $24.66M, a 99.39% increase from fiscal 2013.
- ALPINE IMMUNE SCIENCES, INC. debt conversion, converted instrument, amount for fiscal 2013 was $12.37M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-13 | $12.29M derived: sum of 2 quarters · filed 2017-02-13 | $24.66M 10-K · filed 2017-02-13 | |
| 2014-09-30 | $12.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $24.70M 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | $12.37M 10-Q · filed 2015-08-04 | |||
| 2013-12-31 | $12.37M 10-K · filed 2016-03-08 |